Literature DB >> 6274968

Persistent infection with adenovirus types 5 and 6 in lymphoid cells from humans and woolly monkeys.

W A Andiman, G Miller.   

Abstract

Chronic infection with adenovirus types 5 and 6 was established in primary mononuclear leukocytes from human umbilical cord blood and in Epstein-Barr virus (EBV)-transformed B lymphocytes from human umbilical cord blood and from woolly monkey blood. Adenovirus could be recovered from cultures of primary leukocytes and of EBV-transformed lymphocytes for two and three months, respectively, without visible alteration of cell growth. Infection in cultures of EBV-transformed lymphocytes from woolly monkey blood was obliterated by exposure to antibody, but EBV-transformed lymphocytes from human umbilical cord blood contained small amounts of virus for prolonged periods that restored infection in the culture when antibody was removed. Thus, chronic infection of lymphoid cells by some adenoviruses is maintained by at least two mechanisms: cell-to-cell spread of virus in the absence of antibody and intracellular persistence of infectious virus in the presence of antibody.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6274968     DOI: 10.1093/infdis/145.1.83

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Adenovirus E3-6.7K maintains calcium homeostasis and prevents apoptosis and arachidonic acid release.

Authors:  Alexander R Moise; Jason R Grant; Timothy Z Vitalis; Wilfred A Jefferies
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines.

Authors:  Adrienne L McNees; Jeff A Mahr; David Ornelles; Linda R Gooding
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  A human cell line selected for resistance to adenovirus infection has reduced levels of the virus receptor.

Authors:  P Freimuth
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

4.  Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines.

Authors:  D Matteucci; M Paglianti; A M Giangregorio; M R Capobianchi; F Dianzani; M Bendinelli
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

5.  Nonpermissivity of human peripheral blood lymphocytes to adenovirus type 2 infection.

Authors:  J Horvath; J M Weber
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

6.  Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines.

Authors:  A Segerman; Y F Mei; G Wadell
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Adenoviral infections in pediatric liver transplant recipients.

Authors:  B Koneru; R Jaffe; C O Esquivel; R Kunz; S Todo; S Iwatsuki; T E Starzl
Journal:  JAMA       Date:  1987 Jul 24-31       Impact factor: 56.272

8.  Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter.

Authors:  C Ebbinghaus; A Al-Jaibaji; E Operschall; A Schöffel; I Peter; U F Greber; S Hemmi
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

9.  Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells.

Authors:  S Huang; T Kamata; Y Takada; Z M Ruggeri; G R Nemerow
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

10.  Group C adenovirus DNA sequences in human lymphoid cells.

Authors:  J Horvath; L Palkonyay; J Weber
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.